Related by context. All words. (Click for frequent words.) 79 Bortezomib 79 Gemcitabine 79 Capecitabine 78 bevacizumab Avastin 78 Erlotinib 78 Trastuzumab 78 ACE Inhibitors 77 Pemetrexed 77 Dasatinib 77 Irinotecan 76 Lenalidomide 76 Paraplatin ® 76 Fludarabine 76 Hormone Refractory Prostate Cancer 76 Rituximab 75 Docetaxel 75 Metastatic Colorectal Cancer 75 Pfizer Sutent 75 Meets Primary Endpoint 75 Peginterferon 74 Neoadjuvant 74 Pertuzumab 74 Camptosar ® 74 Gefitinib 74 Fulvestrant 74 erlotinib Tarceva ® 74 Valsartan 74 Aliskiren 74 adalimumab Humira 74 Anti TNF 74 Adjuvant Treatment 74 Vandetanib 74 Monotherapy 73 Pioglitazone 73 Cyclophosphamide 73 Renal Cell Carcinoma 73 sorafenib Nexavar 73 Disease Progression 73 Gemzar ® 73 Dapagliflozin 73 Fluorouracil 73 Avastin bevacizumab 73 Adjuvant Therapy 73 Temsirolimus 73 Investigational Agent 73 Ranibizumab 73 Tiotropium 73 thalidomide Thalomid 73 Herceptin trastuzumab 73 Nilotinib 73 Alemtuzumab 73 Tocilizumab 73 Azacitidine 73 Amrubicin 73 Mitoxantrone 73 Degarelix 73 mycophenolate mofetil 73 Oxaliplatin 73 Boceprevir 73 FASLODEX 73 Anastrozole 73 Imatinib 73 Fondaparinux 73 Antitumor Activity 73 paclitaxel Taxol 72 Torisel 72 Sorafenib 72 FOLFIRI 72 Aflibercept 72 Taxotere ® 72 5 Fluorouracil 72 Exemestane 72 bevacizumab Avastin ® 72 Everolimus 72 Tumor Necrosis Factor 72 Previously Treated 72 Platinol ® 72 Pazopanib 72 Decitabine 72 Ranolazine 72 Advanced Renal Cell 72 Adjuvant Chemotherapy 72 Medoxomil 72 Improves Survival 72 Prolongs Survival 72 trastuzumab Herceptin 72 Etanercept 72 Treated Patients 72 mTOR inhibitor 72 pegylated liposomal doxorubicin 72 Cytarabine 72 Cisplatin 72 Radioimmunotherapy 72 Pegylated Interferon 72 Vidaza azacitidine 72 Survival Benefit 72 JAK Inhibitor 72 Anti Tumor Activity 72 Melphalan 71 Carboplatin 71 Moxifloxacin 71 AVASTIN 71 Epratuzumab 71 PEGylated Fab fragment 71 Patients Treated With 71 Peginterferon Alfa 2a 71 Investigational Treatment 71 Golimumab 71 DOXIL 71 temsirolimus 71 Mg Usa 71 Epidermal Growth Factor Receptor 71 Pooled Analysis 71 Adalimumab 71 Anti Tumor 71 Unfractionated Heparin 71 Sapacitabine 71 Glatiramer Acetate 71 Posaconazole 71 Previously Untreated 71 FOLFOX6 71 gefitinib Iressa 71 Myelodysplastic Syndromes 71 imatinib Gleevec 71 Newly Diagnosed Multiple Myeloma 71 Fludara 71 ZOLINZA 71 gemcitabine Gemzar 71 pertuzumab 71 Patients Treated 71 Bivalirudin 71 Azathioprine 71 Doxorubicin 71 Methylnaltrexone 71 Eculizumab 71 Cetuximab 71 idarubicin 71 Hycamtin 71 Advanced Colorectal Cancer 71 TNF Tumor Necrosis Factor 71 azacytidine 71 cetuximab Erbitux 71 Metastatic Prostate Cancer 71 Drug Candidate 71 Infliximab 71 Epoetin Alfa 71 cetuximab Erbitux ® 71 Phase IIb Trial 71 Diuretic 71 dacarbazine 71 Rosiglitazone 71 Androgen Deprivation Therapy 70 sorafenib tablets 70 Novel Oral 70 Investigational Compound 70 anti angiogenic agent 70 Well Tolerated 70 Long Term Efficacy 70 IRESSA 70 Doxil ® 70 Tipranavir 70 Study Evaluating 70 Colorectal Cancer Patients 70 Combination Therapy 70 Lubiprostone 70 dasatinib Sprycel 70 Refractory Hodgkin Lymphoma 70 interferon gamma 1b 70 Bevacizumab Avastin 70 Immunosuppression 70 Advanced Melanoma 70 etanercept Enbrel 70 TYKERB 70 Pegylated Liposomal Doxorubicin 70 Elderly Patients 70 Bosutinib 70 Ofatumumab 70 Pegylated 70 Salmeterol 70 Methotrexate 70 Complicated Skin 70 Tacrolimus 70 Allergic Rhinitis 70 Interferon beta 1a 70 Pulmonary Arterial Hypertension 70 standard chemotherapy regimen 70 Randomized Phase 70 Ziprasidone 70 Lung Cancer Patients 70 Tasigna nilotinib 70 Anthracycline 70 bortezomib Velcade 70 tyrosine kinase inhibitor 70 Zolinza 70 Tyrosine Kinase Inhibitor 70 Eltrombopag 70 Bisphosphonate 70 Pivotal Phase III 70 Improved Survival 70 Phase 2b Study 70 mRCC 70 Xelox 70 Velcade bortezomib 70 lapatinib Tykerb 70 FOLFOX4 70 Navelbine ® 70 Pharmacokinetic Study 70 Combination Treatment 70 ZD# [001] 70 Patients Receiving 70 PKC# 70 Advanced Prostate Cancer 70 Lupus Nephritis 70 Mipomersen 70 erlotinib Tarceva 70 cetuximab Erbitux R 70 Natalizumab 70 Sipuleucel T 70 Nexavar ® 70 Zoledronic Acid 70 Oral Fingolimod 70 HER2 Positive Breast Cancer 70 Taxotere docetaxel 70 GW# [003] 70 carboplatin paclitaxel 70 Dose Escalation 70 biologic therapy 70 infliximab Remicade 70 receptor tyrosine kinase inhibitor 70 Investigational Drug 70 Relapsed Refractory 70 Doxil 70 Interferon Beta 70 Benign Prostatic Hyperplasia 70 Naive Patients 70 Myeloma Patients 70 Voreloxin 69 Disease Modifying 69 alfa 2a 69 Losartan 69 Epirubicin 69 Diabetic Nephropathy 69 Bosentan 69 Cholesterol Lowering Drug 69 Lacosamide 69 Metastatic Renal Cell Carcinoma 69 Phase 2b Clinical Trial 69 Follicular Lymphoma 69 Mg Uk 69 Amiodarone 69 Autologous Stem Cell Transplantation 69 Inhaled Corticosteroids 69 Romiplostim 69 Cutaneous T 69 Low Dose 69 cinacalcet 69 Abatacept 69 dasatinib Sprycel ® 69 tocilizumab 69 Intravitreal 69 Bucindolol 69 Noxafil 69 Riluzole 69 leflunomide 69 Corticosteroids 69 Tolerability 69 Glufosfamide 69 Trabectedin 69 Teriparatide 69 Rivaroxaban 69 Generic Version 69 Darunavir 69 Chronic Hepatitis C 69 YONDELIS 69 Lapatinib 69 Zarnestra 69 Nucleoside 69 Hycamtin ® 69 Relapsed Refractory Multiple Myeloma 69 Blood Pressure Drug 69 Study Showed 69 Hypertensive Patients 69 Taxol ® 69 Pixantrone 69 Chronic Lymphocytic Leukemia 69 Newly Diagnosed 69 Pralatrexate 69 azacitidine 69 Treatment Naive Patients 69 Granulocyte Colony Stimulating Factor 69 Efficacious 69 Copegus ribavirin 69 Interferon alfa 69 Fluticasone 69 Ambrisentan 69 Chronic Myeloid Leukemia 69 Overactive Bladder 69 5 fluorouracil leucovorin 69 Cyclooxygenase 2 69 Roche Actemra 69 Tezampanel 69 Pivotal Phase 69 Fingolimod 69 Hypercholesterolemia 69 Cilostazol 69 Calcitonin 69 Tanespimycin 69 Carvedilol 69 Sitagliptin 69 Heart Failure Patients 69 Pirfenidone 69 sunitinib malate 69 Antiangiogenic 69 Rheumatoid Arthritis Patients 69 Phase III Trials 69 Phase III Clinical Trial 69 Demonstrates Efficacy 69 Diabetic Patients 69 Aurora Kinase 69 alkylating agent 69 TEMODAL 69 sertraline Zoloft 69 Trastuzumab Herceptin 69 Taxane 69 Sanofi Aventis Taxotere 69 angiotensin converting enzyme inhibitors 69 GAMMAGARD LIQUID 68 Lamivudine 68 BANZEL 68 Tarceva erlotinib 68 Talabostat 68 Phase 2a Trial 68 Single Dose 68 Lamotrigine 68 Safinamide 68 Fluconazole 68 Improve Survival 68 topotecan 68 imatinib Gleevec ® 68 Ixempra 68 Montelukast 68 Node Positive 68 nilotinib Tasigna 68 Cardiotoxicity 68 Dabigatran 68 Raltegravir 68 R lenalidomide 68 angiotensin receptor blocker ARB 68 Paclitaxel 68 Relapsed Multiple Myeloma 68 Neulasta ® 68 Ibritumomab Tiuxetan 68 5 FU leucovorin 68 capecitabine Xeloda 68 NDA Submission 68 Is Well Tolerated 68 Metastatic Melanoma 68 complement inhibitor eculizumab 68 cediranib 68 Novartis Gleevec 68 SPRYCEL ® 68 Severe Sepsis 68 proteasome inhibitor 68 Hepatitis C Patients 68 Epivir 68 docetaxel Taxotere 68 metastatic hormone refractory 68 Pediatric Patients 68 Receptor Antagonists 68 Myelodysplastic Syndrome 68 mapatumumab 68 Phase III Trial 68 Sulfonylurea 68 Aortic Stenosis 68 5-FU/LV 68 MAGE A3 ASCI 68 Clinical Trial Results 68 Dalbavancin 68 Ramipril 68 ixabepilone 68 Rheumatoid Arthritis Drug 68 Topotecan 68 tenofovir Viread 68 Improves Outcomes 68 sunitinib Sutent ® 68 Lung Cancer Drug 68 INTEGRILIN R 68 Hsp# Inhibitor 68 fluoropyrimidine 68 Castration Resistant Prostate Cancer 68 Tarceva TM 68 galiximab 68 TAXOTERE R 68 vorinostat 68 Relapsing Multiple Sclerosis 68 metastatic renal cell carcinoma 68 estramustine 68 Gleevec imatinib 68 MGd 68 infusional 5-FU/LV 68 Clopidogrel 68 luteinizing hormone releasing 68 Fludara ® 68 HER2 positive metastatic breast 68 HuMax EGFr 68 Donepezil 68 Interferon Alfa 68 Xanafide 68 glatiramer acetate 68 Hormone Receptor Positive 68 sunitinib Sutent 68 Receptor Agonist 68 pemetrexed 68 Enzyme Replacement Therapy 68 nilotinib 68 EGFr 68 Zorbtive TM 68 BRAF inhibitor 68 hormone refractory metastatic prostate 68 rivastigmine Exelon 68 icatibant 68 Tigecycline 68 XYOTAX TM 68 Pharmacokinetics PK 68 Mycophenolate Mofetil 68 Paclitaxel Carboplatin 68 MEK Inhibitor 68 Relapsing Remitting Multiple Sclerosis 68 paroxetine Paxil 68 Roche Xeloda 68 Prospective Randomized 68 Diabetic Neuropathy 68 ritonavir boosted 68 Proton Pump Inhibitor 68 Leucovorin 68 efalizumab 68 Phase 2a Clinical Trial 68 Nexavar sorafenib 68 Shows Efficacy 68 trabectedin 68 STELARA TM 68 Malignant Melanoma 68 Estrogen Receptor 68 Antipsychotic 68 VAPRISOL 68 Colchicine 68 Perifosine 68 nucleoside analog 68 Tumor Response 68 Levofloxacin 68 Insulin Glargine 68 Taxol paclitaxel 68 Parnate 68 Transdermal Patch 68 proteasome inhibitors 68 Cloretazine 68 Ustekinumab 68 Clinical Trial Evaluating 68 Vfend 68 Vidaza ® 68 LY# [003] 68 demethylating agent 68 bevacizumab Avastin R 68 Inhalation Solution 68 Diabetic Macular Edema 68 Cabazitaxel 68 aspirin clopidogrel 68 xanthine oxidase inhibitor 68 T#I [002] 68 Ribavirin 68 Budesonide 68 oxaliplatin Eloxatin 68 Colesevelam HCl 68 metastatic malignant 68 Chemotherapy Improves 68 fulvestrant 68 efavirenz EFV 68 TYGACIL 68 Increased Mortality 68 Combination therapy 68 Fewer Side Effects 68 Teriflunomide 68 Peginterferon alfa 2b 68 Breast Cancer Recurrence 67 PEGINTRON TM 67 Ezetimibe 67 Solid Tumors 67 Corticosteroid 67 docetaxel Taxotere ® 67 Pafuramidine 67 angiotensin II receptor blocker 67 ADP receptor antagonist 67 BAY #-# 67 Chronic Sinusitis 67 Xeloda capecitabine 67 Traficet EN 67 vincristine doxorubicin 67 Novel Mechanism 67 Phase IIb Clinical Trial 67 CIMZIA ™ 67 DFMO 67 amifostine 67 Kinase Inhibitor 67 Fixed Dose 67 bevacizumab 67 raloxifene Evista 67 APTIVUS 67 Peg IFN 67 Resistant Hypertension 67 SIMCOR 67 PEGylated anti 67 alendronate Fosamax 67 Prophylactic Treatment 67 tigecycline 67 cyclophosphamide methotrexate 67 Darbepoetin Alfa 67 Novantrone 67 diclofenac Voltaren 67 FUSILEV enhances 67 basiliximab 67 Ozarelix 67 ACE Inhibitor 67 DMARDS 67 pimozide 67 Enzastaurin 67 boosted protease inhibitor 67 abatacept Orencia 67 Dose Ranging Study 67 HDAC Inhibitor 67 Plus Ribavirin 67 pan HDAC inhibitor 67 metaglidasen 67 direct thrombin inhibitors 67 Treatment Regimen 67 decitabine 67 Acute Myeloid Leukemia 67 Vimpat R 67 alefacept 67 Maraviroc 67 angiogenesis inhibitor 67 Kinase Inhibitors 67 Progenitor Cells 67 Vicriviroc 67 bendamustine 67 haloperidol Haldol 67 Renal Impairment 67 Recombinant Human 67 TORISEL 67 MYCAMINE 67 Tesamorelin 67 Vaprisol 67 Chemoradiation 67 Erectile Dysfunction Drug 67 gemcitabine chemotherapy 67 Oral Formulation 67 Leukine ® 67 Myelodysplastic Syndrome MDS 67 Clofarabine 67 Cinacalcet 67 Expanded Indication 67 anakinra 67 Janssen Risperdal 67 rFVIIa 67 leukotriene receptor antagonist 67 Bicalutamide 67 rosuvastatin Crestor 67 Femara letrozole 67 dexamethasone Decadron 67 LHRH 67 Acute Pancreatitis 67 Deforolimus 67 EGFR TKI 67 fluvastatin 67 aripiprazole Abilify 67 Acute Ischemic Stroke 67 pegylated interferon alfa 2a 67 Vildagliptin 67 Subgroup Analysis 67 Hydroxyurea 67 Preclinical Data 67 beta 1a 67 alpha blocker 67 Anti VEGF 67 Radiofrequency Ablation RFA 67 Bazedoxifene 67 Sevelamer 67 Abacavir 67 Galantamine 67 Adefovir 67 Potent Anti 67 Malignant Glioma 67 Breast Cancer Cells 67 Etravirine 67 Ecallantide 67 Oral Anticoagulant 67 MyVax R 67 Panitumumab 67 pegfilgrastim 67 dasatinib 67 Cytoxan 67 Enoxaparin 67 tolvaptan 67 Neoadjuvant Chemotherapy 67 APTIVUS r 67 ULORIC 67 Gastrointestinal Stromal Tumors 67 chemotherapeutic regimen 67 Romidepsin 67 refractory chronic lymphocytic 67 R pioglitazone HCl 67 calcineurin inhibitors 67 Carfilzomib 67 Oral Mucositis 67 Combo Therapy 67 low dose cytarabine 67 interferon alfa 67 Ixabepilone 67 Lenocta 67 myelofibrosis polycythemia vera 67 panitumumab Vectibix 67 Ridaforolimus 67 relapsing multiple sclerosis 67 Zoledronic acid 67 Tumor Growth 67 cilengitide 67 antimetabolite 67 BARACLUDE R 67 Fabry Disease 67 Rilonacept 67 fluorouracil 67 Pegasys ® 67 Mylan Receives Approval 67 candesartan cilexetil 67 PEG interferon 67 Rituxan rituximab 67 gemcitabine carboplatin 67 Remicade infliximab 67 cabazitaxel 67 Demonstrated Significant 67 Daclizumab 67 Mouse Model 67 Intravesical 67 gastrointestinal stromal tumors GIST 67 multitargeted 67 Beta Blockers 67 bleomycin 67 Valopicitabine 67 Anticoagulant 67 Omalizumab 67 Zoloft sertraline 67 idraparinux 67 Knee Osteoarthritis 67 Kidney Transplant Patients 67 Jevtana 67 Liposomal 67 Controlled Trial 67 Myelofibrosis 67 paclitaxel Taxol ® 67 Palifosfamide 67 BARACLUDE ® 67 Pregabalin 67 Denufosol 67 glitazone 67 epoetin beta 67 immunosuppressant drug 67 Panzem R 67 Genentech Rituxan 67 ELOXATIN 67 Randomized Phase II 67 INC# 67 Camptosar 67 Glimepiride 67 somatostatin analogue 67 Fracture Risk 67 Carboplatin Paclitaxel 67 Demonstrates Potent 67 Cholinesterase Inhibitors 66 reslizumab 66 ZYVOX 66 Osteoporosis Drug 66 Avanafil 66 Gene Mutation 66 leucovorin 66 Prostate Cancer Patients 66 Anticancer Drugs 66 Inhalation Aerosol 66 pegylated interferon alfa 66 Non Responders 66 Soft Tissue Sarcoma 66 CAELYX 66 vandetanib 66 Telmisartan 66 metastatic castration resistant 66 melphalan prednisone 66 Low Density Lipoprotein Cholesterol 66 Betaferon R 66 Signaling Pathway 66 Temozolomide 66 Vidaza R 66 Elotuzumab 66 Hepatocellular Carcinoma 66 Entecavir 66 Neuroprotective Effects 66 metformin HCl 66 metastatic colorectal 66 PegIntron 66 ST Elevation Myocardial 66 trastuzumab Herceptin ® 66 chemotherapy cisplatin 66 alpha 2a 66 Vorinostat 66 Clolar ® 66 Treatment Resistant 66 IV Busulfex 66 histone deacetylase HDAC inhibitor 66 Leukine 66 nucleotide analogue 66 Taxanes 66 Abbott HUMIRA 66 AstraZeneca Symbicort 66 Statistically Significant 66 Candesartan 66 Alkeran 66 Diffuse Large B 66 Atypical Hemolytic Uremic Syndrome 66 selective modulator 66 Celecoxib 66 doxazosin 66 flutamide 66 Rigel R# 66 ribavirin RBV 66 Treatment Reduces 66 cyclosporin 66 multi kinase inhibitor 66 Nebulized 66 Renal Function 66 letrozole Femara 66 Allogeneic 66 temsirolimus Torisel 66 Stomach Cancer 66 ZACTIMA 66 immunomodulatory therapy 66 Maribavir 66 insulin sensitizing 66 Etoposide 66 Amikacin 66 docetaxel chemotherapy 66 ONGLYZA ™ 66 echinocandin 66 Bendamustine 66 II Clinical Trial 66 mertansine 66 Sandostatin R 66 Xeloda ® 66 INTELENCE 66 dexpramipexole 66 oral dual endothelin 66 Sunitinib 66 Placebo Controlled Study 66 abacavir Ziagen 66 goserelin 66 Antiplatelet 66 Anticancer Activity 66 pegaptanib 66 irbesartan 66 Shows Statistically Significant 66 temsirolimus Torisel ® 66 Hydrochlorothiazide 66 IL# PE#QQR 66 ergot derivatives 66 Rasagiline 66 CYP#A# substrate 66 selegiline 66 Replacement Therapy 66 Unresectable 66 XELOX 66 Certolizumab 66 Demonstrates Positive 66 Angiotensin Converting Enzyme 66 Filgrastim 66 Invasive Breast Cancer 66 gemcitabine cisplatin 66 Cremophor 66 Statin Therapy 66 Peginterferon Alfa 2b 66 cytostatic 66 oral antidiabetic 66 olmesartan 66 AMN# [001] 66 TO AVOID PREGNANCY WHILE 66 zoledronate 66 Kepivance 66 targeted radiotherapeutic 66 Cimetidine 66 Temodar ® 66 cancer mCRC 66 Interferon Alpha 66 Didanosine 66 vinca alkaloids 66 Initiate Clinical Trial 66 ACTEMRA TM 66 Sustained Release 66 Vincristine 66 Vidofludimus 66 administered concomitantly 66 Placebo Controlled Trial 66 proteasome inhibitor bortezomib 66 Randomized Clinical Trial 66 CYT# potent vascular disrupting 66 cetuximab 66 Versus Placebo 66 Tamibarotene 66 Nitazoxanide 66 IgG1 monoclonal antibody 66 Antitumor 66 Vinorelbine 66 Ticagrelor 66 Seliciclib 66 esomeprazole Nexium 66 Lilly Gemzar 66 meropenem 66 Fibrates 66 TREANDA 66 Phase 2b Trial 66 Zileuton 66 eplerenone 66 Chemokine Receptor 66 Cladribine 66 investigational humanized monoclonal antibody 66 Bafetinib 66 Pravastatin 66 Celebrex celecoxib 66 Ganciclovir 66 Aviptadil 66 NOXAFIL 66 pharmacokinetic interactions 66 Gleevec Glivec 66 Treanda 66 Ceftaroline 66 Cytotoxic 66 Pegintron 66 Tesetaxel 66 Progressive Multifocal Leukoencephalopathy 66 systemic antifungal 66 FDA Approvals 66 Clevudine 66 ara C 66 induced macular edema 66 Retinoic Acid 66 AZT zidovudine Retrovir 66 Brain Metastases 66 riociguat 66 regorafenib 66 PREZISTA r 66 mycophenolic acid 66 liposomal doxorubicin 66 Ramelteon 66 ibandronate 66 Novel Inhibitor 66 microtubule inhibitor 66 Rotigotine 66 Topiramate 66 Revlimid lenalidomide 66 Multiple Myeloma Patients 66 Generic Versions 66 Atazanavir 66 ARIMIDEX 66 protease inhibitor PI 66 sunitinib 66 Protease Inhibitor 66 Severe Asthma 66 Pivotal Study 66 nicardipine 66 trastuzumab DM1 66 tenofovir emtricitabine 66 Levodopa 66 sorafenib Nexavar R 66 Liver Failure 66 Drug Combo 66 Tyrosine Kinase Inhibitors 66 Anidulafungin 66 Erythropoietin 66 ribavirin USP 66 mu opioid receptor antagonist 66 Cimzia certolizumab pegol 66 temozolomide 66 biliary tract cancer 66 Bayer Nexavar 66 pegylated interferons 66 Antiviral Activity 66 Regimens 66 venlafaxine Effexor 66 imipenem 66 COPEGUS R 66 Diovan HCT 66 ARIXTRA 66 Cytotoxicity 66 Darusentan 66 Sertraline 66 Bayer Onyx 66 Thiazolidinediones 66 liposomal formulation 66 antifibrinolytic 66 dual endothelin receptor antagonist 66 biologic DMARD 66 vinca alkaloid 66 Monoclonal Antibody 66 tinidazole 66 relapsed ovarian cancer 66 Gout Drug 66 TNF antagonists 66 Interferon beta 1b 66 posaconazole 66 Drug Prevents 66 Squamous Cell Carcinoma 66 Laquinimod 66 oral prodrug 66 azathioprine 66 paclitaxel Taxol R 66 antiplatelet agent 66 Patients Undergoing 66 Oral Cladribine 66 Double Blind Randomized 66 Secondary Hyperparathyroidism 66 Glaxo Tykerb 66 Cyclosporine 66 Clinical Outcome 66 KOMBIGLYZE XR 66 YERVOY 66 Angiotensin 66 Slow Progression 66 exemestane Aromasin 66 Schizophrenia Drug 66 recurrent glioblastoma multiforme 66 unfractionated heparin UFH 66 Treating Chronic 66 ACZ# 65 Febuxostat 65 5FU 65 Interferon beta 65 intravenously administered 65 DAPT 65 Haemophilus b Conjugate 65 nab paclitaxel 65 Danazol 65 chemoradiation therapy 65 Significantly Improved 65 Enlarged Prostate 65 chlorambucil 65 adriamycin 65 Non Steroidal Anti Inflammatory 65 anti androgen 65 tamoxifen citrate 65 Artery Disease 65 Randomized Study 65 Sustiva efavirenz 65 Seasonal Allergic Rhinitis 65 Psoriasis Drug 65 Mirapexin 65 CHOP chemotherapy 65 Telaprevir VX 65 TREDAPTIVE 65 Ropinirole 65 chemotherapeutic drug 65 docetaxel Taxotere R 65 GP IIb IIIa inhibitors 65 Treatment Naïve 65 Orally administered 65 Newly Diagnosed Patients 65 benazepril 65 trastuzumab Herceptin R 65 Elitek 65 Lovastatin 65 cisplatin chemotherapy 65 Genasense R 65 ORENCIA ® 65 clopidogrel Plavix 65 Pfizer Lyrica 65 Muraglitazar 65 Factor Receptor 65 insulin glulisine 65 generation purine nucleoside 65 ® lenalidomide 65 See CLINICAL PHARMACOLOGY 65 tiuxetan 65 DMARD 65 immunotherapeutic agent 65 colesevelam HCl 65 chemotherapy FOLFOX 65 FDA Accepts 65 Starlix 65 rituximab Rituxan 65 Cellcept 65 Intravenous CP 65 atrasentan 65 Systemic Delivery 65 Recurrent Breast Cancer 65 CANCIDAS 65 ORENCIA R